Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy

Small
Jie MengXian-Da Yang

Abstract

The biomedical applications of carbon nanotubes (CNTs) have attracted deep interest in recent years. Antitumor immunotherapy has the potential to improve the prognosis of cancer treatment but the efficacy of current immunotherapy generally needs further improvement. Multi-walled CNTs conjugated to tumor lysate protein are investigated as to whether they would enhance the efficacy of an immunotherapy employing a tumor-cell vaccine in a mouse model bearing the H22 liver cancer. The tumor cure rate is found to be markedly improved by CNTs conjugated to tumor lysate protein. The cellular antitumor immune reaction is also enhanced. Moreover, the observed antitumor immune response is relatively specific against the tumor intended for treatment. These findings suggest that CNTs may have a prospective role in the development of new antitumor immunotherapies.

References

Aug 18, 2001·Cell·J BanchereauG Schuler
Dec 18, 2002·Accounts of Chemical Research·Ya-Ping SunWeijie Huang
Jan 2, 2003·Nature Reviews. Drug Discovery·Charles R Martin, Punit Kohli
Aug 9, 2003·Expert Review of Vaccines·Jeffrey A Sosman, Vernon K Sondak
Dec 24, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David BerdMichael J Mastrangelo
Jan 23, 2004·Chemical Communications : Chem Comm·Davide PantarottoAlberto Bianco
Mar 6, 2004·Seminars in Cancer Biology·Eddy C Hsueh, Donald L Morton
May 4, 2004·Nature Medicine·Carl G FigdorCornelis J M Melief
Jun 4, 2004·Journal of the American Chemical Society·Nadine Wong Shi KamHongjie Dai
Aug 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Theodora FifisMagdalena Plebanski
Sep 30, 2004·Angewandte Chemie·Davide PantarottoAlberto Bianco
Jan 27, 2005·Chemical Communications : Chem Comm·Alberto BiancoMaurizio Prato
Apr 21, 2005·Journal of the American Chemical Society·Nadine Wong Shi Kam, Hongjie Dai
Aug 10, 2005·Proceedings of the National Academy of Sciences of the United States of America·Nadine Wong Shi KamHongjie Dai
Sep 28, 2005·Cancer Immunology, Immunotherapy : CII·Margarita SalcedoThierry Velu
Oct 20, 2005·Current Opinion in Chemical Biology·Alberto BiancoMaurizio Prato
Oct 26, 2005·Journal of Nanoscience and Nanotechnology·Yingchun NiVladimir Parpura
Dec 22, 2005·Chembiochem : a European Journal of Chemical Biology·Lizeng GaoXiyun Yan
Mar 9, 2006·Nano Letters·Laura P ZanelloRobert C Haddon
Mar 23, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yan LuoYu-Quan Wei
Jul 25, 2006·Nature Reviews. Cancer·Alexander J Muller, Peggy A Scherle
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James C Yang, Richard Childs
Dec 16, 2006·International Reviews of Immunology·Frédéric Lévy, Sara Colombetti
Dec 16, 2006·International Reviews of Immunology·John Copier, Angus Dalgleish
Dec 16, 2006·International Reviews of Immunology·Leisha A Emens
Jul 26, 2008·Nature Nanotechnology·Kostas KostarelosAlberto Bianco

❮ Previous
Next ❯

Citations

Oct 8, 2009·Nature Nanotechnology·K KostarelosM Prato
Jul 22, 2009·Proceedings of the National Academy of Sciences of the United States of America·Andrew BurkeSuzy V Torti
Oct 27, 2011·Journal of Drug Delivery·Abdelbary M A ElhissiAntony D'Emanuele
Sep 13, 2013·Journal of Nanobiotechnology·Riccardo Gottardi, Bruno Douradinha
Dec 1, 2010·International Journal of Nanomedicine·Aaron TanAlexander M Seifalian
Oct 7, 2011·International Journal of Nanomedicine·Teodora Mocan, Cornel Iancu
Nov 3, 2010·Nanomedicine·Vivek S ThakareSanyog Jain
Mar 19, 2014·Trends in Biotechnology·Tarek R Fadel, Tarek M Fahmy
Mar 7, 2014·Therapeutic Delivery·Ashaben PatelAshim K Mitra
Sep 24, 2013·Advanced Drug Delivery Reviews·Hélène Dumortier
Aug 1, 2013·Advanced Drug Delivery Reviews·David A ScheinbergSimone Alidori
Jul 17, 2013·Advanced Drug Delivery Reviews·Alessia BattigelliAlberto Bianco
Jan 24, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hatem A F M HassanKhuloud T Al-Jamal
Nov 29, 2014·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Valeria Amenta, Karin Aschberger
Jun 6, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Javier ParraAntonio Abad-Fuentes
Oct 31, 2012·Human Vaccines & Immunotherapeutics·Xin TianGuangjun Nie
Mar 2, 2017·ACS Applied Materials & Interfaces·Man YangHaiyan Xu
Feb 27, 2018·Chemical Society Reviews·Christopher D SpicerMolly M Stevens
Aug 4, 2018·Advanced Healthcare Materials·Jabran SaleemChunying Chen
Nov 13, 2018·Advanced Materials·Thanh Loc NguyenJaeyun Kim
Oct 15, 2011·Nanoscale Research Letters·Wuxu ZhangYingge Zhang
Jun 7, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Yu ZhangGuizhi Zhu
Jun 30, 2019·Advanced Materials·C Wyatt ShieldsSamir Mitragotri
Mar 20, 2012·Chemical Communications : Chem Comm·Chiara FabbroMaurizio Prato
Oct 1, 2019·Current Pharmaceutical Design·Alessandra IscaroMunitta Muthana
Oct 7, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Alessia BattigelliAlberto Bianco
Nov 11, 2019·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jana KubackovaOndrej Holas
Apr 16, 2020·Nano Today·Krystina L HessChristopher M Jewell
Jun 2, 2021·Journal of Hematology & Oncology·Zhe ChengYongheng Chen
Nov 20, 2014·The Journal of Organic Chemistry·Alexander SchwengerClemens Richert
Aug 20, 2021·International Journal of Nanomedicine·Elidamar Nunes de Carvalho LimaJosé Roberto Castilho Piqueira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.